MRK
38
-8
DG
16
-5
GOOGL
54
6
EQR
40
-4
WBA
48
-2
MUR
44
2
XRX
59
2
NSC
71
4
UNH
9
-5
TRV
39
-7
CB
51
-6
INTC
36
4
ZBH
51
-3
APH
86
2
ABT
59
-6
MAC
58
-4
XOM
53
3
GE
77
2
LYB
23
-4
KMI
73
2
MRK
38
-8
DG
16
-5
GOOGL
54
6
EQR
40
-4
WBA
48
-2
MUR
44
2
XRX
59
2
NSC
71
4
UNH
9
-5
TRV
39
-7
CB
51
-6
INTC
36
4
ZBH
51
-3
APH
86
2
ABT
59
-6
MAC
58
-4
XOM
53
3
GE
77
2
LYB
23
-4
KMI
73
2
Financhill
Back

Summit Therapeutics Stock Predictions

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
58

SMMT
Summit Therapeutics

Last Price:
$22.75
Seasonality Move:
6.57%

7 Day Trial

ALL ACCESS PASS

$ 7

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Summit Therapeutics Stock Forecast

  • Over the next 52 weeks, Summit Therapeutics has on average historically risen by 66.6% based on the past 10 years of stock performance.
  • Summit Therapeutics has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
  • Is Summit Therapeutics Stock Undervalued?
    The current Summit Therapeutics [SMMT] share price is $24.61. The Score for SMMT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • SMMT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Summit Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Summit Therapeutics has on average historically risen by 66.6% based on the past 10 years of stock performance.

Summit Therapeutics Stock Rating

Buy
58
Summit Therapeutics (SMMT) is a Buy

Is Summit Therapeutics overpriced?

  • Summit Therapeutics has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%

Summit Therapeutics Stock Price History

Is SMMT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
smmttx.com

52-Week Data

52-Week High:
36.91
52-Week Low:
2.10

Prediction Charts

Market Cap:
18.3B
Price in USD:
24.61
Volume:
2M
Beta:
-0.18

Technical Analysis

SMA50:
22.16
SMA100:
21.01
SMA200:
19.34
52-Wk Change:
412.71%

Stock Predictions

  • Is Summit Therapeutics stock public?
    Yes, Summit Therapeutics is a publicly traded company.
  • What is the Summit Therapeutics stock quote today?
    The Summit Therapeutics stock price is 24.61 USD today.
  • How to buy Summit Therapeutics stock online?
    You can buy Summit Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-24 33.00 36.70 36.91 32.48
Apr-25 34.48 23.47 35.92 22.22
Apr-28 24.38 24.11 26.97 23.04
Apr-29 23.70 23.62 24.54 23.20
Apr-30 22.98 24.12 24.35 22.84
May-1 24.38 24.67 25.21 23.42
May-2 25.93 27.90 29.99 25.81
May-5 27.90 28.02 28.28 26.71
May-6 26.95 24.20 27.09 23.81
May-7 24.54 24.29 24.73 23.80
May-8 24.48 24.65 25.79 23.96
May-9 24.65 23.96 25.34 23.45
May-12 23.26 25.26 25.30 23.26
May-13 25.39 24.61 25.50 24.21

Summit Therapeutics Earnings

Summit Therapeutics Earnings Report: Per Share Summit Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Summit Therapeutics Forecast Revenue Growth

Summit Therapeutics Stock Analysis: Historical quarterly revenues per share for Summit Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.11 per share.

* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.